Clinical Trial

Evaluation of an Oat Fiber Supplement on Health

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to determine whether short-term use of an oat fiber supplement reduces exposure to your urine levels of dietary chemicals like bisphenol A (BPA). This study will also examine whether supplementation with NeutraOat oat fiber influences blood glucose levels using continuous glucose monitoring.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-15.
Trial Details
NCT Number NCT07714135
Lead Sponsor California Polytechnic State University-San Luis Obispo
Conditions Supplementation Efficacy in Health Adults on Plasticizer Removal
Enrollment 40 participants
Start Date 2026-10-01
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-21